365 related articles for article (PubMed ID: 37894474)
1. Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis.
Nirala BK; Yamamichi T; Petrescu DI; Shafin TN; Yustein JT
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894474
[TBL] [Abstract][Full Text] [Related]
2. Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications.
Zhu T; Han J; Yang L; Cai Z; Sun W; Hua Y; Xu J
Front Immunol; 2022; 13():907550. PubMed ID: 35720360
[TBL] [Abstract][Full Text] [Related]
3. Role of microRNAs in the crosstalk between osteosarcoma cells and the tumour microenvironment.
Lei Y; Junxin C; Yongcan H; Xiaoguang L; Binsheng Y
J Bone Oncol; 2020 Dec; 25():100322. PubMed ID: 33083216
[TBL] [Abstract][Full Text] [Related]
4. Cracking the code: Deciphering the role of the tumor microenvironment in osteosarcoma metastasis.
Jin J; Cong J; Lei S; Zhang Q; Zhong X; Su Y; Lu M; Ma Y; Li Z; Wang L; Zhu N; Yang J
Int Immunopharmacol; 2023 Aug; 121():110422. PubMed ID: 37302370
[TBL] [Abstract][Full Text] [Related]
5. Single-cell RNA-seq reveals intratumoral heterogeneity in osteosarcoma patients: A review.
Thomas DD; Lacinski RA; Lindsey BA
J Bone Oncol; 2023 Apr; 39():100475. PubMed ID: 37034356
[TBL] [Abstract][Full Text] [Related]
6. Single-cell transcriptomics reveals the regulative roles of cancer associated fibroblasts in tumor immune microenvironment of recurrent osteosarcoma.
Huang X; Wang L; Guo H; Zhang W; Shao Z
Theranostics; 2022; 12(13):5877-5887. PubMed ID: 35966586
[No Abstract] [Full Text] [Related]
7. Role of the tumor microenvironment in cancer hallmarks and targeted therapy (Review).
Naser R; Fakhoury I; El-Fouani A; Abi-Habib R; El-Sibai M
Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36579669
[TBL] [Abstract][Full Text] [Related]
8. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated macrophages in osteosarcoma.
Zhao Y; Zhang B; Zhang Q; Ma X; Feng H
J Zhejiang Univ Sci B; 2021 Nov; 22(11):885-892. PubMed ID: 34783219
[TBL] [Abstract][Full Text] [Related]
10. Macrophages in Osteosarcoma Immune Microenvironment: Implications for Immunotherapy.
Luo ZW; Liu PP; Wang ZX; Chen CY; Xie H
Front Oncol; 2020; 10():586580. PubMed ID: 33363016
[TBL] [Abstract][Full Text] [Related]
11. The role of tumor-associated macrophages in osteosarcoma progression - therapeutic implications.
Huang Q; Liang X; Ren T; Huang Y; Zhang H; Yu Y; Chen C; Wang W; Niu J; Lou J; Guo W
Cell Oncol (Dordr); 2021 Jun; 44(3):525-539. PubMed ID: 33788151
[TBL] [Abstract][Full Text] [Related]
12. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma.
Liu Z; Liu B; Feng C; Li C; Wang H; Zhang H; Liu P; Li Z; He S; Tu C
Front Immunol; 2022; 13():1071636. PubMed ID: 36569869
[TBL] [Abstract][Full Text] [Related]
14. A Deep Dive Into the Newest Avenues of Immunotherapy for Pediatric Osteosarcoma: A Systematic Review.
Suri M; Soni N; Okpaleke N; Yadav S; Shah S; Iqbal Z; Alharbi MG; Kalra HS; Hamid P
Cureus; 2021 Sep; 13(9):e18349. PubMed ID: 34725602
[TBL] [Abstract][Full Text] [Related]
15. Development of personalized classifier based on metastasis and the immune microenvironment to predict the prognosis of osteosarcoma patients.
Zhang Z; Yuan J; Wang Y; Zhang Y; Guan Z; Su X; Wang Y
Ann Transl Med; 2022 Dec; 10(24):1346. PubMed ID: 36660665
[TBL] [Abstract][Full Text] [Related]
16. The Immune Landscape of Osteosarcoma: Implications for Prognosis and Treatment Response.
Cascini C; Chiodoni C
Cells; 2021 Jul; 10(7):. PubMed ID: 34359840
[TBL] [Abstract][Full Text] [Related]
17. Osteosarcoma and Metastasis.
Sheng G; Gao Y; Yang Y; Wu H
Front Oncol; 2021; 11():780264. PubMed ID: 34956899
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the Tumor Microenvironment in Osteosarcoma Identifies Prognostic- and Immunotherapy-Relevant Gene Signatures.
Tan J; Feng X; Wu H; Yang B; Shi M; Xie C; Su Z; Li L; Luo M; Zuo Z; Zhu S; Yang J; Lin L
J Immunol Res; 2022; 2022():6568278. PubMed ID: 36065454
[TBL] [Abstract][Full Text] [Related]
19. Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality.
Yu L; Zhang J; Li Y
Front Immunol; 2022; 13():871076. PubMed ID: 36311748
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]